KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Revenue (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Revenue for 17 consecutive years, with $2.8 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 9.26% to $2.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 billion through Dec 2025, up 6.66% year-over-year, with the annual reading at $10.3 billion for FY2025, 6.66% up from the prior year.
  • Revenue hit $2.8 billion in Q4 2025 for Bausch Health Companies, up from $2.7 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $7.2 billion in Q4 2021 to a low of $1.9 billion in Q1 2022.
  • Historically, Revenue has averaged $2.5 billion across 5 years, with a median of $2.2 billion in 2022.
  • Biggest five-year swings in Revenue: surged 227.16% in 2021 and later plummeted 69.71% in 2022.
  • Year by year, Revenue stood at $7.2 billion in 2021, then tumbled by 69.71% to $2.2 billion in 2022, then grew by 9.8% to $2.4 billion in 2023, then grew by 6.27% to $2.6 billion in 2024, then rose by 9.26% to $2.8 billion in 2025.
  • Business Quant data shows Revenue for BHC at $2.8 billion in Q4 2025, $2.7 billion in Q3 2025, and $2.5 billion in Q2 2025.